Results 201 to 210 of about 68,759 (241)

Amyloid β alters vascular CaV1.2 channel spatiotemporal properties

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Amyloid‐β1‐42 (Aβ1‐42) triggers a male‐specific signalling cascade influencing CaV1.2 spatiotemporal properties in cerebral vascular smooth muscle. The signalling pathway involves NADPH oxidase (NOX)‐derived reactive oxygen species (ROS) activation of protein kinase C (PKC). Aβ1‐42 can also activate protein kinase A (PKA).
Jade L. Taylor   +5 more
wiley   +1 more source

Plasma KL-6 reflects pulmonary severity and longitudinal response to enzyme replacement therapy in acid sphingomyelinase deficiency type B. [PDF]

open access: yesMol Genet Metab Rep
Cifuentes-Uribe K   +6 more
europepmc   +1 more source

Professionals and the Ethics of Workplace Surveillance

open access: yes
Journal of Social Philosophy, EarlyView.
Steve Clarke   +2 more
wiley   +1 more source

Caenorhabditis elegans as an in vivo model system for human inherited primary arrhythmia syndromes

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Most genes involved in inherited primary arrhythmia syndromes (IPAS) are conserved in Caenorhabditis elegans, where genetic manipulation enables functional characterization of variants, identification of regulatory proteins, and in vivo drug testing.
Antoine Delinière   +6 more
wiley   +1 more source

Wellness enhancement for caregivers 2.0: feasibility, acceptability, and preliminary 12‐month outcomes for Chinese American dementia caregivers

open access: yesAlzheimer's &Dementia: Behavior &Socioeconomics of Aging, Volume 2, Issue 4, December 2026.
Abstract INTRODUCTION Chinese American dementia caregivers face cultural, linguistic, and service‐access barriers, yet evidence on culturally tailored digital support and 12‐month caregiver outcomes remains limited. METHODS In a single‐arm pilot, 48 caregivers received the 7‐week Chinese‐language Wellness Enhancement for Caregivers 2.0 (WECARE 2.0 ...
Yi‐Wen Li   +7 more
wiley   +1 more source

Renal replacement therapy in type 2 severe cardiorenal syndrome: a randomized controlled trial. [PDF]

open access: yesESC Heart Fail
Schleef M   +9 more
europepmc   +1 more source

National Trends and Disparities in Cancer Mortality Among Individuals With Alzheimer's Disease and Related Dementias in the United States, 1999–2020

open access: yesComputational and Systems Oncology, Volume 6, Issue 1, December 2026.
ABSTRACT As population aging accelerates, the coexistence of cancer and Alzheimer's disease and related dementias (ADRD) is becoming increasingly common. While each condition independently contributes to mortality, national trends in cancer‐related deaths occurring alongside ADRD—and their demographic and geographic disparities—remain poorly defined ...
Aasim Ali   +14 more
wiley   +1 more source

The Rising Burden of Atrial Fibrillation and Respiratory Failure Mortality in the United States: A 25‐Year Nationwide Retrospective Analysis of Death Certificate Data

open access: yesJournal of Arrhythmia, Volume 42, Issue 6, December 2026.
Age‐adjusted mortality rates for deaths recording both atrial fibrillation and respiratory failure among U.S. adults aged ≥ 55 years rose about five‐fold from 1999 to 2024. The rise began before the COVID‐19 pandemic, persisted after excluding deaths listing COVID‐19, and occurred with and without heart failure recorded.
Syed Tawassul Hassan   +5 more
wiley   +1 more source

Oncology Inpatient Resuscitation Planning and Long‐Term “Rapid Response Call” Outcomes

open access: yesAsia-Pacific Journal of Clinical Oncology, Volume 22, Issue 6, Page 801-807, December 2026.
Optimal end‐of‐life care involves a patient‐centered approach. The dual audits presented in this study show that a proportion of oncology patients receiving palliative‐intent cancer treatment continue to be managed in hospital without a resuscitation plan and may undergo care escalation to a “rapid response” intervention despite poor prognosis ...
Dhanashree Tikhe   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy